+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics), and Region - Forecast to 2028

  • ID: 5306672
  • Report
  • March 2021
  • Region: Global
  • 172 Pages
  • Markets and Markets
Global Human Microbiome Market is Projected to Reach USD 1.59 Billion by 2028 from USD 894 Million in 2025, at a CAGR of 21.3%

FEATURED COMPANIES

  • 4D Pharma plc
  • Bione
  • Enterome
  • FlightPath
  • Metabiomics
  • Seres Therapeutics

The global human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.

The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth.

However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth.

By product segment, the drugs segment accounted for the largest share of human microbiome market

Based on product, the human microbiome market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and other products. Drugs segment accounted for the largest product segment in the human microbiome market. The large share of this segment can be attributed to the increasing number of human microbiome-based drug products in clinical trials and rising funding to develop microbiome-based drugs.

By application, the diagnostics segment is expected to grow at the highest CAGR during the forecast period

Based on application, the human microbiome market is segmented into therapeutics and diagnostics. The diagnostics segment is expected to grow at the highest CAGR during the forecast period. Advances in life science research on a wide number of diseases, technological innovations in human genome mapping, the emergence of omics technologies, and the increasing emphasis on improving the cost-effectiveness of healthcare and patient outcomes are some of the major factors driving the growth of this segment.

By genomic technologies, the sequencing segment is expected to grow at the highest CAGR during the forecast period

On the basis of technology, the human microbiome market is further segmented into sequencing and other genomic technologies {PCR, microarray, and fluorescent in situ hybridization (FISH)}. The availability of advanced, efficient, and accurate next-generation sequencing systems at a low cost, along with the reduced cost of sequencing, has greatly boosted the adoption of the latest sequencing technologies in the human microbiome market.

North America: The largest and fastest-growing region in the human microbiome market

In the human microbiome market, North America is estimated to grow at the highest CAGR during the forecast period. Factors such as the increasing incidence of lifestyle diseases, rising awareness on preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products are the factors driving the North American human microbiome market.

Research Coverage

The report segments the human microbiome market based on region (Asia Pacific, Europe, North America, and RoW), product (prebiotics, probiotics, drugs, diagnostic tests, and other products), technology (Genomics, Proteomics, and Metabolomics), application (therapeutics and diagnostics), disease (hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the human microbiome market.

Prominent players in the human microbiome market include ENTEROME Bioscience (France), Seres Therapeutics (US), 4D pharma (UK), Evelo Biosciences (US), OptiBiotix Health (UK), Synlogic (US), Second Genome (US), Vedanta Biosciences (US), Ferring Pharmaceuticals (Switzerland), ViThera Pharmaceuticals (US), BiomX (Israel), DuPont (US), Kaleido (US), YSOPIA Bioscience (France), FlightPath (US), Finch Therapeutics (US), Quantbiome (DBA Thyrve, Inc.) (US), Viome, Inc. (US), DayTwo (US), BIOHM (US), Atlas Biomed (UK), Bione (India), Luxia Scientific (France), Sun Genomics (US), and Metabiomics (US).

Breakdown of Primary Interviews

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Designation: Managers: 55%, Executives: 25%, and CXOs: 20%,
  • By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

Key Benefits of Buying the Report

  1. The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall human microbiome market and its subsegments.
  2. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies.
  3. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 4D Pharma plc
  • Bione
  • Enterome
  • FlightPath
  • Metabiomics
  • Seres Therapeutics

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered for the Human Microbiome Market
1.3.2 Markets Covered for Human Microbiome Research Spending Market
1.3.3 Years Covered for the Study (Human Microbiome Research Spending Market)
1.3.4 Years Covered for the Study (Human Microbiome Diagnostic Applications Markets)
1.3.5 Years Covered for the Study (Human Microbiome Therapeutic Application Markets)
1.4 Currency
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.2 Primary Sources
Figure 1 Breakdown of Primaries: Human Microbiome Market
2.2 Market Data Estimation and Triangulation
Figure 2 Data Triangulation Methodology
2.2.1 Market Estimation Methodology
Figure 3 Market Size Estimation Approach: R&D Spending Analysis-based Estimation (For Human Microbiome Research Spending Market)
Figure 4 Human Microbiome Research Spending Market Size (USD Million): Final Market Size
2.2.2 Growth Rate Assumptions/Growth Forecast
Figure 5 Final CAGR Projections (2020-2025)
2.2.3 Potential Market Size Calculation for Human Microbiome Market
Figure 6 Human Microbiome Market Size Based on Epidemiology Approach
Figure 7 Market Validation from Primary Experts
2.3 Research Assumptions

3 Executive Summary
Figure 8 Human Microbiome Market, by Product, 2025 vs. 2028 (USD Million)
Figure 9 Human Microbiome Market Share, by Application, 2024
Figure 10 Human Microbiome Market, by Disease, 2025 vs. 2028 (USD Million)
Figure 11 Geographical Snapshot of the Human Microbiome Market

4 Premium Insights
4.1 Human Microbiome: Market Overview
Figure 12 Increasing Focus on Human Microbiome Therapeutics Development to Drive the Growth of this Market
4.2 Human Microbiome Research Spending Market, by Technology (2020 vs. 2025)
Figure 13 Genomic Technologies Dominated the Human Microbiome Research Spending Market in 2020
4.3 North America: Human Microbiome Market, by Product & Application (2024)
4.4 Human Microbiome Research Spending Market, by Country (2020-2025)
Figure 14 China to Grow at the Highest CAGR During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Human Microbiome Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Market Drivers
5.2.1.1 Increasing Focus on Human Microbiome Therapeutics Development
5.2.1.2 Human Microbiome as a Validated Target for Drug Development
5.2.1.3 Development of Human Microbiome-based Tests for Early Disease Detection & Diagnosis
5.2.2 Market Opportunities
5.2.2.1 Increasing Collaborations Between Public-Private Organizations
5.2.3 Market Challenges
5.2.3.1 Government Regulations
5.2.3.2 Lack of Expertise and Inadequate Research
5.2.4 Market Restraints
5.2.4.1 Barriers in Proving the Causal Link Between Dysbiosis and Diseases
5.3 Impact of the COVID-19 on the Market
5.4 Technology Analysis
5.5 Regulatory Analysis
5.5.1 For Human Microbiome-based Drugs Category
5.5.2 For Human Microbiome-based Foods Category
5.6 Patent Analysis

6 Human Microbiome Market, by Product
6.1 Introduction
Table 1 Human Microbiome Market, by Product, 2019-2028 (USD Million)
6.2 Drugs
6.2.1 Increasing Number of Microbiome-based Drugs in the Pipeline is a Key Factor Driving Market Growth
Table 2 Human Microbiome Market for Drugs, by Region, 2022-2028 (USD Million)
Table 3 North America: Human Microbiome Market for Drugs, by Country 2022-2028 (USD Million)
6.3 Diagnostic Tests
6.3.1 Growing Consumer Awareness About Microbiome-based Tests to Drive Market Growth
Table 4 Human Microbiome Market for Diagnostic Tests, by Region, 2019-2028 (USD Million)
Table 5 North America: Human Microbiome Market for Diagnostic Tests, by Country 2019-2028 (USD Million)
6.4 Probiotics
6.4.1 Ongoing Research on Probiotics is Promoting Its Credibility in Health Claims and Safety, Thus Driving Market Growth
Table 6 Human Microbiome Market for Probiotics, by Region, 2023-2028 (USD Million)
Table 7 North America: Human Microbiome Market for Probiotics, by Country, 2019-2028 (USD Million)
6.5 Prebiotics
6.5.1 Development of Targeted Prebiotics in Enhancing Gut Microbiota is the Key Growth Driver for this Segment
Table 8 Human Microbiome Market for Prebiotics, by Region, 2023-2028 (USD Million)
Table 9 North America: Human Microbiome Market for Prebiotics, by Country, 2023-2028 (USD Million)
6.6 Other Products
Table 10 Human Microbiome Market for Other Products, by Region, 2023-2028 (USD Million)
Table 11 North America: Human Microbiome Market for Other Products, by Country, 2023-2028 (USD Million)

7 Human Microbiome Market, by Disease
7.1 Introduction
Table 12 Human Microbiome Market, by Disease, 2022-2028 (USD Million)
7.2 Infectious Diseases
7.2.1 Increasing Number of Clinical Studies for Clostridium Difficile Infection to Drive Market Growth
Table 13 Development of Microbiome-based Drugs for Infectious Diseases
Table 14 Human Microbiome Market for Infectious Diseases, by Region, 2022-2027 (USD Million)
Table 15 North America: Human Microbiome Market for Infectious Diseases, by Country, 2022-2028 (USD Million)
7.3 Gastrointestinal Diseases
7.3.1 Increasing Number of Clinical Studies for Gastrointestinal Diseases to Drive Market Growth
Table 16 Human Microbiome Market for Gastrointestinal Diseases, by Region, 2022-2028 (USD Million)
Table 17 North America: Human Microbiome Market for Gastrointestinal Diseases, by Country, 2022-2028 (USD Million)
7.4 Endocrine & Metabolic Disorders
7.4.1 The Development of Microbiome Modulators for the Treatment of Metabolic Disorders Drives Market Growth
Table 18 Human Microbiome Market for Endocrine & Metabolic Disorders, by Region, 2022-2028 (USD Million)
Table 19 North America: Human Microbiome Market for Endocrine & Metabolic Disorders, by Country, 2022-2028 (USD Million)
7.5 Cancer
7.5.1 Microbiome-based Products Have Demonstrated Efficacy in the Treatment of Pelvic and Colon Cancer
Table 20 Human Microbiome Market for Cancer, by Region, 2022-2028 (USD Million)
Table 21 North America: Human Microbiome Market for Cancer, by Country, 2022-2028 (USD Million)
7.6 Other Diseases
Table 22 Human Microbiome Market for Other Diseases, by Region, 2022-2028 (USD Million)
Table 23 North America: Human Microbiome Market for Other Diseases, by Country, 2022-2028 (USD Million)

8 Human Microbiome Market, by Application
8.1 Introduction
Table 24 Human Microbiome Market, by Application, 2019-2028 (USD Million)
8.2 Therapeutic Applications
8.2.1 Availability of Funding for the Development of Microbiome-based Therapeutic Products to Drive Market Growth
Table 25 Human Microbiome Market for Therapeutic Applications, by Region, 2019-2028 (USD Million)
Table 26 North America: Human Microbiome Market for Therapeutic Applications, by Country, 2019-2028 (USD Million)
8.3 Diagnostic Applications
8.3.1 Increasing Focus on Biomarker-based Diagnostic Tests to Drive Market Growth
Table 27 Human Microbiome Market for Diagnostic Applications, by Region, 2019-2028 (USD Million)
Table 28 North America: Human Microbiome Market for Diagnostic Applications, by Country, 2019-2028 (USD Million)

9 Human Microbiome Research Spending Market, by Technology
9.1 Introduction
Table 29 Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
9.2 Genomics
Table 30 Human Microbiome Research Spending Market for Genomics, by Type, 2018-2025 (USD Million)
Table 31 Human Microbiome Research Spending Market for Genomics, by Region, 2018-2025 (USD Million)
Table 32 North America: Human Microbiome Research Spending Market for Genomics, by Country, 2018-2025 (USD Million)
Table 33 Europe: Human Microbiome Research Spending Market for Genomics, by Country, 2018-2025 (USD Million)
Table 34 Asia-Pacific: Human Microbiome Research Spending Market for Genomics, by Country, 2018-2025 (USD Million)
9.2.1 Sequencing
Table 35 Human Microbiome Research Spending Market for Sequencing, by Region, 2018-2025 (USD Million)
Table 36 North America: Human Microbiome Research Spending Market for Sequencing, by Country, 2018-2025 (USD Million)
Table 37 Europe: Human Microbiome Research Spending Market for Sequencing, by Country, 2018-2025 (USD Million)
Table 38 Asia-Pacific: Human Microbiome Research Spending Market for Sequencing, by Country, 2018-2025 (USD Million)
Table 39 Human Microbiome Research Spending Market for Sequencing, by Method, 2018-2025 (USD Million)
9.2.1.1 16S rRNA Sequencing Method
9.2.1.1.1 This Method is a Cost-Effective Technique for the Identification of Bacterial Strains
Table 40 16S rRNA Sequencing Method, by Region, 2018-2025 (USD Million)
Table 41 North America: 16S rRNA Sequencing Method, by Country, 2018-2025 (USD Million)
Table 42 Europe: 16S rRNA Sequencing Method, by Country, 2018-2025 (USD Million)
Table 43 Asia-Pacific: 16S rRNA Sequencing Method, by Country, 2018-2025 (USD Million)
9.2.1.2 Whole-Genome Sequencing (WGS) Method
9.2.1.2.1 WGS Helps Generate Accurate Reference Genomes for Microbial Identification
Table 44 WGS Method, by Region, 2018-2025 (USD Million)
Table 45 North America: WGS Method, by Country, 2018-2025 (USD Million)
Table 46 Europe: WGS Method, by Country, 2018-2025 (USD Million)
Table 47 Asia-Pacific: WGS Method, by Country, 2018-2025 (USD Million)
9.2.1.3 Other Sequencing Methods
Table 48 Other Sequencing Methods, by Region, 2018-2025 (USD Million)
Table 49 North America: Other Sequencing Methods, by Country, 2018-2025 (USD Million)
Table 50 Europe: Other Sequencing Methods, by Country, 2018-2025 (USD Million)
Table 51 Asia-Pacific: Other Sequencing Methods by Country, 2018-2025 (USD Million)
9.2.2 Other Genomic Technologies
Table 52 Human Microbiome Research Spending Market for Other Genomic Technologies, by Region, 2018-2025 (USD Million)
Table 53 North America: Human Microbiome Research Spending Market for Other Genomic Technologies, by Country, 2018-2025 (USD Million)
Table 54 Europe: Human Microbiome Research Spending Market for Other Genomic Technologies, by Country, 2018-2025 (USD Million)
Table 55 Asia-Pacific: Human Microbiome Research Spending Market for Other Genomic Technologies, by Country, 2018-2025 (USD Million)
9.3 Proteomics
9.3.1 Technological Advancements in Proteomic Technologies to Drive Market Growth
Table 56 Proteomics, by Region, 2018-2025 (USD Million)
Table 57 North America: Proteomics, by Country, 2018-2025 (USD Million)
Table 58 Europe: Proteomics, by Country, 2018-2025 (USD Million)
Table 59 Asia-Pacific: Proteomics, by Country, 2018-2025 (USD Million)
9.4 Metabolomics
9.4.1 Advantages of Metabolomics Over Genomics and Proteomics in Microbiome Research to Drive Market Growth
Table 60 Metabolomics, by Region, 2018-2025 (USD Million)
Table 61 North America: Metabolomics, by Country, 2018-2025 (USD Million)
Table 62 Europe: Metabolomics, by Country, 2018-2025 (USD Million)
Table 63 Asia-Pacific: Metabolomics, by Country, 2018-2025 (USD Million)

10 Human Microbiome Market, by Region
10.1 Introduction
Table 64 Human Microbiome Market, by Region, 2019-2028 (USD Million)
Table 65 Human Microbiome Research Spending Market, by Region, 2018-2025 (USD Million)
10.2 North America
Figure 16 North America: Human Microbiome Market Snapshot
Table 66 North America: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 67 North America: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 68 North America: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 69 North America: Human Microbiome Market, by Country, 2019-2025 (USD Million)
Table 70 North America: Human Microbiome Research Spending Market, by Country, 2018-2025 (USD Million)
Table 71 North America: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 72 North America: Genomics Market, by Type, 2018-2025 (USD Million)
Table 73 North America: Sequencing Market, by Method, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 Increasing Investments by NIH in Support of Microbiome Research is Driving the Market Growth in the US
Table 74 US: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 75 US: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 76 US: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 77 US: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 78 US: Genomics Market, by Type, 2018-2025 (USD Million)
Table 79 US: Sequencing Market, by Method, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Increasing Government Support and Funds Support Market Growth for Microbiome Research in Canada
Table 80 Indicative List of Projects on the Human Microbiome in 2018
Table 81 Canada: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 82 Canada: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 83 Canada: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 84 Canada: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 85 Canada: Genomics Market, by Type, 2018-2025 (USD Million)
Table 86 Canada: Sequencing Market, by Method, 2018-2025 (USD Million)
10.3 Europe
Table 87 EU Microbiome Project
Table 88 Europe: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 89 Europe: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 90 Europe: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 91 Europe: Human Microbiome Research Spending Market, by Country, 2018-2025 (USD Million)
Table 92 Europe: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 93 Europe: Genomics Market, by Type, 2018-2025 (USD Million)
Table 94 Europe: Sequencing Market, by Method, 2018-2025 (USD Million)
10.3.1 Germany
10.3.1.1 Extended Applications of Microbiome Research to Therapeutic Areas to Boost the Adoption of Microbiome-based Products in Germany
Table 95 Germany: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 96 Germany: Genomics Market, by Type, 2018-2025 (USD Million)
Table 97 Germany: Sequencing Market, by Method, 2018-2025 (USD Million)
10.3.2 UK
10.3.2.1 Increasing Focus on the Development of Microbiome-based Products in the UK to Drive Market Growth
Table 98 UK: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 99 UK: Genomics Market, by Type, 2018-2025 (USD Million)
Table 100 UK: Sequencing Market, by Method, 2018-2025 (USD Million)
10.3.3 France
10.3.3.1 Increasing Funding to Boost the Development of Microbiome-based Products in Europe
Table 101 France: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 102 France: Genomics Market, by Type, 2018-2025 (USD Million)
Table 103 France: Sequencing Market, by Method, 2018-2025 (USD Million)
10.3.4 RoE
Table 104 RoE: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 105 RoE: Genomics Market, by Type, 2018-2025 (USD Million)
Table 106 RoE: Sequencing Market, by Method, 2018-2025 (USD Million)
10.4 Asia-Pacific
Figure 17 Asia-Pacific: Human Microbiome Market Snapshot
Table 107 Asia-Pacific: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 108 Asia-Pacific: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 109 Asia-Pacific: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 110 Asia-Pacific: Human Microbiome Research Spending Market, by Country, 2018-2025 (USD Million)
Table 111 Asia-Pacific: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 112 Asia-Pacific: Genomics Market, by Type, 2018-2025 (USD Million)
Table 113 Asia-Pacific: Sequencing Market, by Method, 2018-2025 (USD Million)
10.4.1 China
10.4.1.1 a Large Number of Human Microbiome Research Studies are Conducted in China, Thus Driving Market Growth
Table 114 Indicative List of Human Microbiome Research Studies Conducted in China
Table 115 China: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 116 China: Genomics Technology Market, by Type, 2018-2025 (USD Million)
Table 117 China: Sequencing Market, by Method, 2018-2025 (USD Million)
10.4.2 Japan
10.4.2.1 Increasing Focus on Funding for Microbiome-based Products to Drive Market Growth
Table 118 Japan: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 119 Japan: Genomics Market, by Type, 2018-2025 (USD Million)
Table 120 Japan: Sequencing Market, by Method, 2018-2025 (USD Million)
10.4.3 India
10.4.3.1 Government Funding to Drive the Development of Microbiome-based Products in India
Table 121 India: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 122 India: Genomics Market, by Type, 2018-2025 (USD Million)
Table 123 India: Sequencing Market, by Method, 2018-2025 (USD Million)
10.4.4 RoAPAC
Table 124 RoAPAC: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 125 RoAPAC: Genomics Market, by Type, 2018-2025 (USD Million)
Table 126 RoAPAC: Sequencing Market, by Method, 2018-2025 (USD Million)
10.5 Rest of the World (RoW)
Table 127 RoW: Human Microbiome Market, by Product, 2019-2028 (USD Million)
Table 128 RoW: Human Microbiome Market, by Application, 2019-2028 (USD Million)
Table 129 RoW: Human Microbiome Market, by Disease, 2022-2028 (USD Million)
Table 130 RoW: Human Microbiome Research Spending Market, by Technology, 2018-2025 (USD Million)
Table 131 RoW: Genomics Market, by Type, 2018-2025 (USD Million)
Table 132 RoW: Sequencing Market, by Method, 2018-2025 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Company Product Footprint
Figure 18 Product Portfolio Analysis: Human Microbiome Market
11.3 Competitive Scenario
Table 133 Human Microbiome Market: Deals, January 2020-January 2021

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
12.1 Enterome
12.2 Seres Therapeutics
Figure 19 Seres Therapeutics: Company Snapshot (2019)
12.3 4D Pharma plc
Figure 20 4D Pharma plc: Company Snapshot (2019)
12.4 Evelo Biosciences, Inc.
Figure 21 Evel0 Biosciences, Inc.: Company Snapshot (2019)
12.5 OptiBiotix Health plc
Figure 22 OptiBiotix Health plc: Company Snapshot (2019)
12.6 Synlogic
Figure 23 Synlogic: Company Snapshot (2019)
12.7 Second Genome
12.8 Vedanta Biosciences, Inc.
12.9 Ferring Pharmaceuticals
12.10 ViThera Pharmaceuticals, Inc.
12.11 BiomX
Figure 24 BiomX: Company Snapshot (2019)
12.12 DuPont
Figure 25 DuPont: Company Snapshot (2019)
12.13 Kaleido
Figure 26 Kaleido: Company Snapshot (2019)
12.14 YSOPIA Bioscience
12.15 FlightPath
12.16 Finch Therapeutics Group, Inc.
12.17 Quantbiome, Inc. (DBA Thryve)
12.18 Viome, Inc.
12.19 DayTwo Inc.
12.20 BIOHM
12.21 Atlas Biomed Group Limited
12.22 Bione
12.23 Luxia Scientific
12.24 Sun Genomics
12.25 Metabiomics
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations

Note: Product cover images may vary from those shown
  • 4D Pharma plc
  • Atlas Biomed Group Limited
  • BIOHM
  • BiomX
  • Bione
  • DayTwo Inc.
  • DuPont
  • Enterome
  • Evelo Biosciences, Inc.
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group, Inc.
  • FlightPath
  • Kaleido
  • Luxia Scientific
  • Metabiomics
  • OptiBiotix Health plc
  • Quantbiome, Inc. (DBA Thryve)
  • Second Genome
  • Seres Therapeutics
  • Sun Genomics
  • Synlogic
  • Vedanta Biosciences, Inc.
  • Viome, Inc.
  • ViThera Pharmaceuticals, Inc.
  • YSOPIA Bioscience
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll